Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8706 USD | +2.06% | +3.64% | -38.69% |
Mar. 19 | Tranche Update on Zepp Health Corporation's Equity Buyback Plan announced on November 16, 2021. | CI |
Mar. 19 | Transcript : Zepp Health Corporation, Q4 2023 Earnings Call, Mar 18, 2024 |
Sales 2024 * | 2.3B 318M | Sales 2025 * | 2.73B 377M | Capitalization | 378M 52.23M |
---|---|---|---|---|---|
Net income 2024 * | -131M -18.1M | Net income 2025 * | -112M -15.47M | EV / Sales 2024 * | 0.16 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
-11.6
x | P/E ratio 2025 * |
-13.6
x | Employees | 839 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 33.95% |
Latest transcript on Zepp Health Corporation
1 day | +2.06% | ||
1 week | +3.64% | ||
Current month | -14.65% | ||
1 month | -14.65% | ||
3 months | -33.03% | ||
6 months | -13.22% | ||
Current year | -38.69% |
Managers | Title | Age | Since |
---|---|---|---|
Wang Huang
CEO | Chief Executive Officer | 48 | 13-12-26 |
Leon Cheng Deng
DFI | Director of Finance/CFO | 41 | 20-09-30 |
Mei Hui Fan
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-08-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bing Xie
BRD | Director/Board Member | 57 | 20-11-21 |
Hong Jiang Zhang
BRD | Director/Board Member | 63 | 18-01-31 |
De Liu
BRD | Director/Board Member | 51 | 15-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.8706 | +2.06% | 34,341 |
24-04-26 | 0.853 | +1.55% | 51,560 |
24-04-25 | 0.84 | -1.18% | 35,131 |
24-04-24 | 0.85 | 0.00% | 48,037 |
24-04-23 | 0.85 | +1.19% | 35,542 |
Delayed Quote Nyse, April 29, 2024 at 04:10 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.69% | 52.22M | |
+26.16% | 2.01B | |
-15.40% | 1.11B | |
+75.54% | 875M | |
+10.96% | 818M | |
-9.74% | 778M | |
+44.37% | 673M | |
-26.82% | 373M | |
-9.59% | 289M | |
+27.76% | 165M |
- Stock Market
- Equities
- ZEPP Stock